 | • レポートコード：QYR9ST01885 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の抗精神病薬市場について調査・分析し、以下の構成でお届け致します。抗精神病薬の種類別には、第一抗精神病薬、第二抗精神病薬、第三抗精神病薬に、用途別には、統合失調症、双極性障害、単極うつ病、痴呆、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別抗精神病薬売上データ ・地域別抗精神病薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別抗精神病薬市場規模：第一抗精神病薬、第二抗精神病薬、第三抗精神病薬 ・用途別抗精神病薬市場規模：統合失調症、双極性障害、単極うつ病、痴呆、その他 ・主要メーカーの企業情報：AstraZeneca、Eli Lilly、GlaxoSmithKline、Johnson & Johnson、Actavis Generics、Alkermes、Bristol-Myers Squibb ・抗精神病薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
The global Antipsychotic Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antipsychotic Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Antipsychotic Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antipsychotic Drugs in these regions.
This research report categorizes the global Antipsychotic Drugs market by top players/brands, region, type and end user. This report also studies the global Antipsychotic Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Actavis Generics
Alkermes
Bristol-Myers Squibb
Market size by Product
First Antipsychotic Drugs
Second Antipsychotic Drugs
Third Antipsychotic Drugs
Market size by End User
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Antipsychotic Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Antipsychotic Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Antipsychotic Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Antipsychotic Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Antipsychotic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antipsychotic Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Antipsychotic Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antipsychotic Drugs Market Size Growth Rate by Product
1.4.2 First Antipsychotic Drugs
1.4.3 Second Antipsychotic Drugs
1.4.4 Third Antipsychotic Drugs
1.5 Market by End User
1.5.1 Global Antipsychotic Drugs Market Size Growth Rate by End User
1.5.2 Schizophrenia
1.5.3 Bipolar Disorder
1.5.4 Unipolar Depression
1.5.5 Dementia
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antipsychotic Drugs Market Size
2.1.1 Global Antipsychotic Drugs Revenue 2014-2025
2.1.2 Global Antipsychotic Drugs Sales 2014-2025
2.2 Antipsychotic Drugs Growth Rate by Regions
2.2.1 Global Antipsychotic Drugs Sales by Regions
2.2.2 Global Antipsychotic Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antipsychotic Drugs Sales by Manufacturers
3.1.1 Antipsychotic Drugs Sales by Manufacturers
3.1.2 Antipsychotic Drugs Sales Market Share by Manufacturers
3.1.3 Global Antipsychotic Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Antipsychotic Drugs Revenue by Manufacturers
3.2.1 Antipsychotic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Antipsychotic Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Antipsychotic Drugs Price by Manufacturers
3.4 Antipsychotic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Antipsychotic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antipsychotic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Antipsychotic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Antipsychotic Drugs Sales by Product
4.2 Global Antipsychotic Drugs Revenue by Product
4.3 Antipsychotic Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Antipsychotic Drugs Breakdown Data by End User
6 North America
6.1 North America Antipsychotic Drugs by Countries
6.1.1 North America Antipsychotic Drugs Sales by Countries
6.1.2 North America Antipsychotic Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antipsychotic Drugs by Product
6.3 North America Antipsychotic Drugs by End User
7 Europe
7.1 Europe Antipsychotic Drugs by Countries
7.1.1 Europe Antipsychotic Drugs Sales by Countries
7.1.2 Europe Antipsychotic Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antipsychotic Drugs by Product
7.3 Europe Antipsychotic Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Antipsychotic Drugs by Countries
8.1.1 Asia Pacific Antipsychotic Drugs Sales by Countries
8.1.2 Asia Pacific Antipsychotic Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antipsychotic Drugs by Product
8.3 Asia Pacific Antipsychotic Drugs by End User
9 Central & South America
9.1 Central & South America Antipsychotic Drugs by Countries
9.1.1 Central & South America Antipsychotic Drugs Sales by Countries
9.1.2 Central & South America Antipsychotic Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antipsychotic Drugs by Product
9.3 Central & South America Antipsychotic Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Antipsychotic Drugs by Countries
10.1.1 Middle East and Africa Antipsychotic Drugs Sales by Countries
10.1.2 Middle East and Africa Antipsychotic Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antipsychotic Drugs by Product
10.3 Middle East and Africa Antipsychotic Drugs by End User
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Antipsychotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Antipsychotic Drugs Products Offered
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Company Business Overview
11.2.3 Eli Lilly Antipsychotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Eli Lilly Antipsychotic Drugs Products Offered
11.2.5 Eli Lilly Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 Company Business Overview
11.3.3 GlaxoSmithKline Antipsychotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 GlaxoSmithKline Antipsychotic Drugs Products Offered
11.3.5 GlaxoSmithKline Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Business Overview
11.4.3 Johnson & Johnson Antipsychotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Johnson & Johnson Antipsychotic Drugs Products Offered
11.4.5 Johnson & Johnson Recent Development
11.5 Actavis Generics
11.5.1 Actavis Generics Company Details
11.5.2 Company Business Overview
11.5.3 Actavis Generics Antipsychotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Actavis Generics Antipsychotic Drugs Products Offered
11.5.5 Actavis Generics Recent Development
11.6 Alkermes
11.6.1 Alkermes Company Details
11.6.2 Company Business Overview
11.6.3 Alkermes Antipsychotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Alkermes Antipsychotic Drugs Products Offered
11.6.5 Alkermes Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Company Business Overview
11.7.3 Bristol-Myers Squibb Antipsychotic Drugs Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Bristol-Myers Squibb Antipsychotic Drugs Products Offered
11.7.5 Bristol-Myers Squibb Recent Development
12 Future Forecast
12.1 Antipsychotic Drugs Market Forecast by Regions
12.1.1 Global Antipsychotic Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Antipsychotic Drugs Revenue Forecast by Regions 2019-2025
12.2 Antipsychotic Drugs Market Forecast by Product
12.2.1 Global Antipsychotic Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Antipsychotic Drugs Revenue Forecast by Product 2019-2025
12.3 Antipsychotic Drugs Market Forecast by End User
12.4 North America Antipsychotic Drugs Forecast
12.5 Europe Antipsychotic Drugs Forecast
12.6 Asia Pacific Antipsychotic Drugs Forecast
12.7 Central & South America Antipsychotic Drugs Forecast
12.8 Middle East and Africa Antipsychotic Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antipsychotic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Antipsychotic Drugs Product Picture
Table Antipsychotic Drugs Market Segments
Table Key Manufacturers Antipsychotic Drugs Covered
Table Global Antipsychotic Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Antipsychotic Drugs Sales Market Share by Product 2014-2025
Figure First Antipsychotic Drugs Product Picture
Table Major Manufacturers of First Antipsychotic Drugs
Figure Second Antipsychotic Drugs Product Picture
Table Major Manufacturers of Second Antipsychotic Drugs
Figure Third Antipsychotic Drugs Product Picture
Table Major Manufacturers of Third Antipsychotic Drugs
Table Global Antipsychotic Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Schizophrenia
Figure Bipolar Disorder
Figure Unipolar Depression
Figure Dementia
Figure Others
Figure Antipsychotic Drugs Report Years Considered
Figure Global Antipsychotic Drugs Market Size 2014-2025 (Million US$)
Figure Global Antipsychotic Drugs Sales 2014-2025 (K Units)
Table Global Antipsychotic Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Antipsychotic Drugs Sales by Regions 2014-2019 (K Units)
Table Global Antipsychotic Drugs Sales Market Share by Regions 2014-2019
Figure Global Antipsychotic Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Antipsychotic Drugs Sales Market Share by Regions
Table Global Antipsychotic Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Antipsychotic Drugs Revenue Market Share by Regions 2014-2019
Figure Global Antipsychotic Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Antipsychotic Drugs Revenue Market Share by Regions
Table Global Antipsychotic Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Antipsychotic Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Antipsychotic Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Antipsychotic Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Antipsychotic Drugs Revenue Share by Manufacturers (2014-2019)
Figure Antipsychotic Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Antipsychotic Drugs Price (2014-2019) (USD/Unit)
Table Antipsychotic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Antipsychotic Drugs Product Type
Table Date of International Manufacturers Enter into Antipsychotic Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Antipsychotic Drugs Sales by Product (2014-2019) (K Units)
Table Global Antipsychotic Drugs Sales Share by Product (2014-2019)
Figure Global Antipsychotic Drugs Sales Market Share by Product (2014-2019)
Figure Global Antipsychotic Drugs Sales Market Share by Product in 2018
Table Global Antipsychotic Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Antipsychotic Drugs Revenue Share by Product (2014-2019)
Figure Global Antipsychotic Drugs Revenue Market Share by Product (2014-2019)
Figure Global Antipsychotic Drugs Revenue Market Share by Product in 2018
Table Antipsychotic Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Antipsychotic Drugs Sales by End User (2014-2019) (K Units)
Table Global Antipsychotic Drugs Sales Share by End User (2014-2019)
Figure Global Sales Antipsychotic Drugs Market Share by End User (2014-2019)
Figure Global Sales Antipsychotic Drugs Market Share by End User in 2018
Figure North America Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Antipsychotic Drugs Sales by Countries (2014-2019) (K Units)
Table North America Antipsychotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Antipsychotic Drugs Sales Market Share by Countries
Table North America Antipsychotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Antipsychotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Antipsychotic Drugs Revenue Market Share by Countries
Figure United States Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Antipsychotic Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Antipsychotic Drugs Sales by Product (2014-2019) (K Units)
Table North America Antipsychotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Antipsychotic Drugs Market Share by Product
Table North America Antipsychotic Drugs Sales by End User (2014-2019) (K Units)
Table North America Antipsychotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Antipsychotic Drugs Market Share by End User
Figure Europe Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Antipsychotic Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Antipsychotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Antipsychotic Drugs Sales Market Share by Countries
Table Europe Antipsychotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Antipsychotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Antipsychotic Drugs Revenue Market Share by Countries
Figure Germany Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Antipsychotic Drugs Sales by Product (2014-2019) (K Units)
Table Europe Antipsychotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Antipsychotic Drugs Market Share by Product
Table Europe Antipsychotic Drugs Sales by End User (2014-2019) (K Units)
Table Europe Antipsychotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Antipsychotic Drugs Market Share by End User
Figure Asia Pacific Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Antipsychotic Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Antipsychotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antipsychotic Drugs Sales Market Share by Countries
Table Asia Pacific Antipsychotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Antipsychotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Antipsychotic Drugs Revenue Market Share by Countries
Figure China Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Antipsychotic Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Antipsychotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Antipsychotic Drugs Market Share by Product
Table Asia Pacific Antipsychotic Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Antipsychotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Antipsychotic Drugs Market Share by End User
Figure Central & South America Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Antipsychotic Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Antipsychotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antipsychotic Drugs Sales Market Share by Countries
Table Central & South America Antipsychotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Antipsychotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Antipsychotic Drugs Revenue Market Share by Countries
Figure Brazil Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Antipsychotic Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Antipsychotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Antipsychotic Drugs Market Share by Product
Table Central & South America Antipsychotic Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Antipsychotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Antipsychotic Drugs Market Share by End User
Figure Middle East and Africa Antipsychotic Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Antipsychotic Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Antipsychotic Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Antipsychotic Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antipsychotic Drugs Sales Market Share by Countries
Table Middle East and Africa Antipsychotic Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Antipsychotic Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Antipsychotic Drugs Revenue Market Share by Countries
Figure GCC Countries Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Antipsychotic Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Antipsychotic Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Antipsychotic Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Antipsychotic Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Antipsychotic Drugs Market Share by Product
Table Middle East and Africa Antipsychotic Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Antipsychotic Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Antipsychotic Drugs Market Share by End User
Table AstraZeneca Company Details
Table AstraZeneca Antipsychotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Antipsychotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Eli Lilly Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Antipsychotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Antipsychotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Johnson & Johnson Recent Development
Table Actavis Generics Company Details
Table Actavis Generics Antipsychotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Actavis Generics Recent Development
Table Alkermes Company Details
Table Alkermes Antipsychotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Alkermes Recent Development
Table Bristol-Myers Squibb Company Details
Table Bristol-Myers Squibb Antipsychotic Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Recent Development
Table Global Antipsychotic Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Antipsychotic Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Antipsychotic Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Antipsychotic Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Antipsychotic Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Antipsychotic Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Antipsychotic Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Antipsychotic Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Antipsychotic Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Antipsychotic Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Antipsychotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Antipsychotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Antipsychotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Antipsychotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Antipsychotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Antipsychotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Antipsychotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Antipsychotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Antipsychotic Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Antipsychotic Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Antipsychotic Drugs Value Chain
Table Antipsychotic Drugs Customers List
Table Antipsychotic Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
精神分裂病治療法の世界市場：市場規模・現状・予測 Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.The second-generation antipsychotic drugs segment accounted for the majority market shares because these dr…- 精神分裂病治療法の世界市場：市場規模・現状・予測 Schizophrenia therapeutics are used as a standard treatment regimen for schizophrenia. It helps in reversing the low levels of dopamine and serotonin, thereby improving the patient's condition.The second-generation antipsychotic drugs segment accounted for the majority market shares because these dr…
- 認知症薬の世界市場：インサイト・予測 The global Dementia Drugs market is valued at 13900 million US$ in 2018 and will reach 26500 million US$ by the end of 2025, growing at a CAGR of 8.4% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dementia Drugs market based on company, product ty…
- 精神分裂病治療薬の世界市場：インサイト・予測 Schizophrenia is a mental disorder characterized by abnormal social behavior and failure to understand reality. Common symptoms include false beliefs, unclear or confused thinking, hearing voices that others do not, reduced social engagement and emotional expression, and a lack of motivation.The glo…
- タイサブリ薬の世界市場：インサイト・予測 Tysabri (natalizumab) is a monoclonal antibody used in to treat relapsing forms of multiple sclerosis. Tysabri is also used to treat moderate to severe Crohn's disease in adults. Tysabri is usually given after other Crohn's disease medications have been tried without successful treatment of this con…